A mild treatment of the resveratrol analogue 3,5,4′-trimethoxystilbene 2 with m-CPBA afforded two hydroxylated methoxystilbenes 5 and 6 by direct aromatic hydroxylation. A similar protocol was applied to other stilbenes bearing a 3,5-dimethoxy moiety, namely tetramethoxystilbenes 7 and 10 to obtain respectively the hydroxylated analogues 8, 9 and 11, 12. The substrate 2 and the new compounds 5, 8 and 11 were evaluated as anti-angiogenic agents and proved significantly active in the range 1 – 100 μM.
(a) TakaokaMJ. (1940) Phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.). Journal Faculty Science Hokkaido Imperial University, 3, 1–16
2.
(b) NonomuraS, KanagawaH, MakimotoA. (1963) Chemical constituents of polygonaceous plants. I. Components of Polygonum cuspidatum. Yakugaku Zasshi, 83, 988–990.
3.
RenaudS, de LorgerilM. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet, 339, 1523–1526.
4.
(a) BradamanteS, BarenghiL, VillaA. (2004) Cardiovascular protective effects of resveratrol. Cardiovascular Drug Reviews, 22, 169–188
5.
(b) AggarwalBB, ShishodiaS. (2006) Oxidative Stress and DiseaseVol 20. Resveratrol in Health and Disease.Taylor & Francis, London. 1–712 pp.
6.
(a) JeandetP, BessisR, SbaghiM, MeunierP, TrollatP. (1995) Resveratrol content of wines of different ages: relationship with fungal disease pressure in the vineyard. American Journal of Enology and Viticulture, 46, 1–4
7.
(b) BaurJA, SinclairDA. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery, 5, 493–506
8.
(c) BurjonroppaS, FujiseK. (2006) Resveratrol as cardioprotective agent: evidence from bench and bedside. In Resveratrol in Health and Disease, AggarwalBB, ShishodiaS. (Eds). Taylor & Francis, London, 555–555
9.
(d) SignorelliP, GhidoniR. (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. Journal of Nutritional Biochemistry, 16, 449–466
10.
(e) DelmasD, LançonA, ColinD, JanninB, LatruffeN. (2006) Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Current Drug Targets, 7, 423–442
11.
(f) JazirehiAR, BonavidaB. (2006) Resveratrol as a sensitizer to apoptosis-inducing stimuli. In Resveratrol in health and disease.AggarwalBB, ShishodiaS. (Eds). Taylor & Francis, London, 399–421.
(b) SaleS, VerschoyleRD, BoocockD, JonesDJL, WilsherN, RupareliaKC, PotterGA, FarmerPB, StewardWP, GescherAJ. (2004) Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans-3,4,5,4′-tetramethoxystilbene. British Journal of Cancer, 90, 744–744
14.
(c) TronGC, PiraliT, SorbaG, PagliaiF, BusaccaS, GenazzaniAA. (2006) Medicinal chemistry of combretastatin A4: Present and future directions. Journal of Medicinal Chemistry, 49, 3033–3044
15.
(d) BelleriM, RibattiD, VicoliS, CotelliF, FortiL, TanniniV, StivalaLA, PrestaM. (2005) Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4′-trimethoxystilbene. Molecular Pharmacology, 67, 1451–1459.
16.
(a) GrasselliF, BasiniG, BussolatiS, TamaniniC. (2002) Effect of reduced oxygen tension on reactive oxygen species production and activity of antioxidant enzymes in swine granulosa cells. Reproduction in Domestic Animals, 37, 362–368
17.
(b) GrasselliF, BasiniG, TirelliM, CavalliV, BussolatiS, TamaniniC. (2003) Angiogenic activity of porcine granulosa cells co-cultured with endothelial cells in a microcarrier-based three-dimensional fibrin gel. Journal of Physiology and Pharmacology, 54, 361–370
18.
(c) GrasselliF, BasiniG, BiancoF, TirelliM, TamaniniC. (2004) Effect of reduced oxygen tension on reactive oxygen species production and activity of antioxidant enzymes in swine granulosa cells. Biofactors, 20, 61–69
19.
(d) BasiniG, BiancoF, GrasselliF, TirelliM, BussolatiS, TamaniniC. (2004) The effects of reduced oxygen tension on swine granulosa cell. Regulatory Peptides, 120, 69–75
20.
(e) BiancoF, BasiniG, GrasselliF. (2005) Angiogenic activity of swine granulosa cells: effects of hypoxia and vascular endothelial growth factor Trap R1R2, a VEGF blockerDomestic Animal Endocrinology, 28, 308–319.
21.
(a) BasiniG, BussolatiS, SantiniSE, GrasselliF. (2007) Sanguinarine inhibits VEGF-induced angiogenesis in a fibrin gel matrix. Biofactors, 29, 11–18
22.
(b) BasiniG, BussolatiS, SantiniSE, BianchiF, CareriM, MangiaA, MusciM, GrasselliF. (2007) Anti-angiogenesis in swine ovarian follicle: A potential role for 2-methoxyestradiol. Steroids, 72, 660–665
(e) FernandoNH, HurwitzHI. (2003) Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer. Seminars in Oncology, 30, 39–50.
26.
(a) CardileV, LombardoL, SpataforaC, TringaliC. (2005) Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. Bioorganic Chemistry, 33, 22–33
27.
(b) CardileV, ChillemiR, LombardoL, SciutoS, SpataforaC, TringaliC. (2007) Antiproliferative activity of methylated analogues of E- and Z-resveratrol. Zeitschrift fur Naturforschung C, 62, 189–195.
28.
RobertiM, PizziraniD, RecanatiniM, SimoniD, GrimaudoS, Di CristinaA, AbbadessaV, GebbiaN, TolomeoM. (2006) Identification of a Terphenyl Derivative that Blocks the Cell Cycle in the G0-G1 Phase and Induces Differentiation in Leukemia Cells. Journal of Medicinal Chemistry, 49, 3012–3018.
29.
ZhangL, GellerstedG. (1994) Reactive structures in wood and high-yield pulps. IV. Daylight-induced oxidation of stilbene structures in the solid state. Acta Chemica Scandinavica, 48, 490–497.
30.
BjorsvikH-R, OcchipintiG, GambarottiC, CerasinoL, JensenVR. (2005) Synthesis of methoxy-substituted phenols by peracid oxidation of the aromatic ring. Journal of Organic Chemistry, 70, 7290–7296.
31.
PotterGA, ButlerPC, RupareliaKC, IjazT, WilsherNC, WanoghoE, TanHL, HoangTTV, StanleyLA, BurkeMD. (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. British Journal of Cancer, 86, 774–8.
32.
BachelorFW, LomanAA, SnowdonLR. (1970) Synthesis of pinosylvin and related heartwood stilbenes. Canadian Journal of Chemistry, 48, 1554–1557.
33.
MannilaE, TalvitieA, KolehmainenE. (1993) Antileukemic compounds derived from stilbenes in Picea abies bark. Phytochemistry, 33, 813–816.
LiY-Q, LiZ-L, ZhaoW-J, WenR-X, MengQ-W, ZengY. (2006) Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication. European Journal of Medicinal Chemistry, 41, 1084–1089.
36.
KimS, KoH, ParkJE, JungS, LeeSK, ChunY–J. (2002) Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. Journal of Medicinal Chemistry, 45, 160–164.
37.
CarrilloS, ChamorroM, Rodriguez-GagoB, AlvarezMJ, MolinaJI, Rodriguez-BarbosaA, SanchezP, RamirezA, MunozJ, DominguezJ, ParrillaP, YelamosJ. (2002) Isolation and characterization of immortalized porcine aortic endothelial cell lines. Veterinary Immunology and Immunopathology, 89, 91–98.
38.
MOPAC2007 (version 7.101), Stewart, J. J. P. Stewart Computational Chemistry, Colorado Springs, CO, USA, http://OpenMOPAC.net, 2007.
39.
SendaN. 3D-Graphics program for program for Molecular Modelling and Visualization of Quantum Chemical Calculations, http://winmostar.com/index_en.html.
